Yesterday I started Wegovy!

Wegovy, containing semaglutide, is a prescription medication administered as a subcutaneous injection typically starting at 0.25 mg doses. It is approved for long-term weight management in adults struggling with obesity or overweight conditions, often alongside lifestyle changes like diet and exercise. Common side effects during initial weeks, such as mild dizziness, nausea, or reduced appetite, often improve as the body adjusts. Increasing water intake and focusing on protein-rich foods can help mitigate these symptoms and support overall nutrition, especially when appetite is suppressed, as noted in early experiences. Patients may find it challenging to eat regular meals initially; small, nutrient-dense portions such as soups or smoothies can be easier to tolerate. Gradually increasing dosage under medical supervision helps improve tolerance and effectiveness. It is crucial to follow a healthcare provider’s guidance for dosing schedules and to report any persistent or severe side effects promptly. Additionally, involving a dietitian can enhance dietary choices to support weight loss goals while maintaining energy and nutrient balance. Wegovy is part of a broader weight loss journey and should be seen as a tool complemented by behavioral changes, exercise, and psychological support to maximize long-term success and health improvements.